The AFib paradox: fewer diagnoses, worse outcomes
Black Americans carry more of nearly everything that causes atrial fibrillation: high blood pressure, type 2 diabetes, obesity, and heart failure. By that logic they should be diagnosed with AFib more often. The opposite shows up in the data. In the REasons for Geographic and Racial Differences in Stroke (REGARDS) study, which followed 13,688 adults free of AFib for a median of about 9 years, Black participants had roughly half the relative risk of developing recorded AFib compared with White participants, even while carrying significantly more diabetes, hypertension, and obesity. Researchers call this the "AFib paradox," and differences in how those risk factors act do not explain it.
The leading explanation is that much of the gap is a detection gap, not a real difference in disease. In the Multi-Ethnic Study of Atherosclerosis (MESA), researchers strapped ambulatory heart monitors on participants instead of relying only on what clinics had recorded. Clinically detected AFib was much lower in Black participants than White participants, but monitor-detected AFib showed little racial difference. AFib is happening in Black patients at closer to the same rate. It is being caught and written down far less often.
What AFib actually is
The heart's two upper chambers, the atria, are supposed to squeeze in a steady, coordinated rhythm. In atrial fibrillation they quiver instead, fast and out of sync. Blood that should be pushed cleanly through the heart pools in a small pouch called the left atrial appendage. Pooled blood clots. When a clot breaks loose, it travels to the brain and blocks an artery there, which is a stroke. That mechanism is why AFib is dangerous out of proportion to how it feels.
The same conditions that are more common in Black adults are what stretch and scar the atria over time: years of high blood pressure, diabetes, obesity, sleep apnea, and heart failure. If high blood pressure runs in your life, read our guide on high blood pressure in Black men, because getting it to target is one of the most direct ways to protect against AFib and its complications.
Symptoms, including the ones that feel like nothing
AFib often announces itself, but not always. The signs people most often report:
- Palpitations, a racing, pounding, fluttering, or skipping heartbeat.
- Fatigue and reduced exercise tolerance, feeling winded by stairs you used to climb easily.
- Shortness of breath, sometimes with chest discomfort or pressure.
- Dizziness or lightheadedness, and in some people, fainting.
Some people feel none of it. AFib can be silent, and the first sign can be a stroke. That is part of why it goes undiagnosed, and why people who do feel symptoms should never explain them away. If your fatigue and breathlessness come with loud snoring and daytime sleepiness, look at our guide on sleep apnea in Black adults, since untreated sleep apnea is a strong driver of AFib.
How AFib is found
AFib is found by catching the irregular rhythm in the act, which is why a normal reading on one office visit does not rule it out. The tools, from simplest to most thorough:
- A pulse check. A clinician (or you) feeling an irregularly irregular pulse is the oldest clue and still a real one.
- An ECG (EKG). A short recording of the heart's electrical activity, the standard test. It is definitive only if AFib is happening during the recording.
- A Holter or patch monitor. A wearable that records continuously for 24 hours up to about 14 days, which catches AFib that comes and goes.
- A smartwatch or single-lead device. Consumer wearables can flag an irregular rhythm. An alert is not a diagnosis, but it is a reason to get a medical recording. Bring the data to your clinician.
The MESA finding matters here. AFib that only shows up on a monitor is exactly the AFib that gets missed when a busy clinic relies on a single normal ECG. If you have symptoms and risk factors, ask for longer monitoring rather than settling for one clean tracing.
The stroke connection and CHA2DS2-VASc
AFib raises the risk of ischemic stroke roughly fivefold and is behind about 1 in 7 strokes in the United States. Clinicians estimate that risk with a score called CHA2DS2-VASc, which adds points for congestive heart failure, hypertension, age 75 and older (2 points), diabetes, prior stroke or clot (2 points), vascular disease, age 65 to 74, and female sex. The higher the score, the higher the yearly stroke risk, and the score is what guides whether you should be on a blood thinner.
The point of the score is action. A man with a CHA2DS2-VASc of 2 or more, or a woman with 3 or more, generally benefits from an oral anticoagulant. If you have been told you have AFib, ask what your CHA2DS2-VASc score is and whether you should be on a blood thinner. That single question closes a gap that data show falls hardest on Black patients.
Treatment, and the documented gaps
AFib treatment runs on two tracks. Rate control slows a fast heart with medications so it pumps efficiently. Rhythm control tries to restore and hold a normal rhythm, with antiarrhythmic drugs or with catheter ablation, a procedure that burns or freezes the small areas of heart tissue firing off the abnormal signals. Running alongside both is anticoagulation, the blood thinners that prevent the clots that cause AFib strokes. Anticoagulation is the part that saves lives, and it is the part most often missed.
The gaps are measured, not theoretical. In a study of 111,666 patients with new AFib in the Veterans Health Administration, a system with uniform drug access, Black patients had lower odds of starting any anticoagulant (adjusted odds ratio 0.90) and substantially lower odds of starting a direct oral anticoagulant, the safer, easier modern blood thinner (adjusted odds ratio 0.74), than White patients. Black patients are also about 10% less likely to receive catheter ablation. And Black patients with AFib have higher rates of stroke and death. Lower treatment, worse outcomes, in the same disease.
None of this is biology. It is detection, referral, and prescribing. The fix on the patient side is to know the treatment exists and to ask for it: a blood thinner if your stroke score warrants one, a referral to a heart-rhythm specialist (an electrophysiologist) if your AFib is symptomatic or hard to control, and a real conversation about ablation rather than waiting to be offered it.
How to get care
Start with a clinician who takes intermittent symptoms seriously and will monitor long enough to catch them. At your next visit, name your risk factors (high blood pressure, diabetes, obesity, heart failure, sleep apnea, family history), report any palpitations or breathlessness, and ask three questions: Should I wear a heart monitor to check for AFib? If I have AFib, what is my CHA2DS2-VASc score and should I be on a blood thinner? Should I see an electrophysiologist about rhythm control or ablation? If you want a cardiologist or heart-rhythm specialist who will hear your history without dismissing it, find a Black cardiologist or electrophysiologist in our directory.
Frequently asked questions
If Black patients get AFib diagnosed less often, does that mean they have less of it? ▼
No. The lower diagnosis rate is largely a detection gap. When researchers in the MESA study used continuous heart monitors instead of relying on clinic records, the Black-White difference in AFib mostly disappeared. AFib is occurring at closer to the same rate; it is being caught and recorded far less often in Black patients. That undetected AFib still causes strokes.
Why do Black patients have worse AFib outcomes if they are diagnosed less? ▼
Undiagnosed AFib goes untreated, so clots and strokes happen. On top of that, Black patients with diagnosed AFib are less likely to be started on a stroke-preventing blood thinner (in one VA study the adjusted odds of starting a direct oral anticoagulant were 0.74 versus White patients) and about 10% less likely to get catheter ablation. Less detection plus less treatment produces higher rates of stroke and death.
What does AFib feel like? ▼
Often a racing, pounding, fluttering, or skipping heartbeat (palpitations), along with fatigue, shortness of breath, reduced exercise tolerance, or dizziness. Some people feel nothing at all, and the first sign can be a stroke. If you have symptoms and risk factors, ask to be checked even if you have had a normal ECG before.
Can a smartwatch diagnose AFib? ▼
A smartwatch or single-lead device can flag an irregular rhythm and is a real reason to get checked, but it is not a diagnosis on its own. Save the alert and any recording the device makes and bring it to your clinician, who can confirm AFib with a medical ECG or a Holter or patch monitor.
What is CHA2DS2-VASc and why does it matter? ▼
It is the score clinicians use to estimate your yearly stroke risk from AFib, adding points for heart failure, high blood pressure, older age, diabetes, prior stroke, vascular disease, and female sex. It decides whether you should be on a blood thinner: generally yes for men scoring 2 or more and women scoring 3 or more. Ask your clinician what your score is.
Is catheter ablation worth asking about? ▼
Yes, if your AFib is symptomatic or hard to control with medication. Ablation targets the heart tissue firing off the abnormal signals to restore a normal rhythm. Black patients are less likely to be referred for it, so it is worth raising directly with a heart-rhythm specialist (an electrophysiologist) rather than waiting for the option to be offered.
